03:39 AM EST, 12/20/2024 (MT Newswires) -- Sarah Boyce, Director, President and Chief Executive Officer, on December 18, 2024, sold 31,855 shares in Avidity Biosciences ( RNA ) for $1,040,384. Following the Form 4 filing with the SEC, Boyce has control over a total of 265,308 shares of the company, with 265,308 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1599901/000159990124000205/xslF345X05/wk-form4_1734650152.xml